FI812338L - 9-amino-1-hydroxyoktahydrobenzo/c/kinoliner och deras derivat - Google Patents

9-amino-1-hydroxyoktahydrobenzo/c/kinoliner och deras derivat

Info

Publication number
FI812338L
FI812338L FI812338A FI812338A FI812338L FI 812338 L FI812338 L FI 812338L FI 812338 A FI812338 A FI 812338A FI 812338 A FI812338 A FI 812338A FI 812338 L FI812338 L FI 812338L
Authority
FI
Finland
Prior art keywords
kinoliner
hydroxyoktahydrobenzo
amino
och deras
derivat
Prior art date
Application number
FI812338A
Other languages
English (en)
Finnish (fi)
Inventor
Michael Ross Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI812338L publication Critical patent/FI812338L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI812338A 1980-07-28 1981-07-27 9-amino-1-hydroxyoktahydrobenzo/c/kinoliner och deras derivat FI812338L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
FI812338L true FI812338L (fi) 1982-01-29

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812338A FI812338L (fi) 1980-07-28 1981-07-27 9-amino-1-hydroxyoktahydrobenzo/c/kinoliner och deras derivat

Country Status (29)

Country Link
US (1) US4309545A (de)
EP (1) EP0045171B1 (de)
JP (1) JPS57112372A (de)
KR (1) KR850000273B1 (de)
AR (1) AR230988A1 (de)
AT (1) ATE11775T1 (de)
AU (1) AU525944B2 (de)
CA (1) CA1178274A (de)
CS (1) CS228515B2 (de)
DD (1) DD202012A5 (de)
DE (1) DE3168891D1 (de)
DK (1) DK334581A (de)
EG (1) EG15535A (de)
ES (1) ES8301926A1 (de)
FI (1) FI812338L (de)
GR (1) GR75283B (de)
GT (1) GT198170557A (de)
HU (1) HU185133B (de)
IE (1) IE51426B1 (de)
IL (1) IL63423A0 (de)
IN (1) IN158867B (de)
NO (2) NO812557L (de)
NZ (1) NZ197856A (de)
PH (1) PH17281A (de)
PL (1) PL133928B1 (de)
PT (1) PT73440B (de)
SU (1) SU1217254A3 (de)
YU (1) YU185181A (de)
ZA (1) ZA815128B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
EA001205B1 (ru) * 1996-01-31 2000-12-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Новые фенантридины
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
WO1999005113A1 (en) * 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-phenylphenanthridines
DE69808099T2 (de) * 1997-07-25 2003-05-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
HUP0203437A3 (en) 1999-03-22 2003-07-28 Immugen Pharmaceuticals Inc So Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US20070254950A1 (en) * 2004-05-25 2007-11-01 Othera Pharmaceuticals, Inc. Oculoselective Drugs and Prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180917B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
EP0045171A3 (en) 1982-04-28
PL232331A1 (en) 1983-09-26
IL63423A0 (en) 1981-10-30
ES504323A0 (es) 1982-12-16
AU7343481A (en) 1982-05-06
IE51426B1 (en) 1986-12-24
DD202012A5 (de) 1983-08-24
US4309545A (en) 1982-01-05
EP0045171A2 (de) 1982-02-03
ZA815128B (en) 1982-07-28
CA1178274A (en) 1984-11-20
NO854454L (no) 1985-01-29
PT73440A (en) 1981-08-01
SU1217254A3 (ru) 1986-03-07
EG15535A (en) 1986-09-30
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
PH17281A (en) 1984-07-06
JPS57112372A (en) 1982-07-13
IE811686L (en) 1982-01-28
YU185181A (en) 1983-12-31
AR230988A1 (es) 1984-08-31
GT198170557A (es) 1983-01-12
EP0045171B1 (de) 1985-02-13
PL133928B1 (en) 1985-07-31
ES8301926A1 (es) 1982-12-16
PT73440B (en) 1983-06-20
HU185133B (en) 1984-12-28
AU525944B2 (en) 1982-12-09
DE3168891D1 (en) 1985-03-28
KR830006217A (ko) 1983-09-20
IN158867B (de) 1987-02-07
NO812557L (no) 1982-01-29
KR850000273B1 (ko) 1985-03-15
GR75283B (de) 1984-07-13
NZ197856A (en) 1984-10-19
ATE11775T1 (de) 1985-02-15

Similar Documents

Publication Publication Date Title
FI811762L (fi) Ml-236b-derivater och deras framstaellning
FI812652L (fi) Aminosyraderivat foerfarande foer deras framstaellning dessa innehaollande aemnen och deras anvaendning
FI813408L (fi) Karbostyril-foereningar kompositioner innehaollande dessa och foerfarande foer deras framstaellning
FI813346L (fi) Foerpackningar och omslag foer multienheter
FI813872L (fi) Blekningsaktivator-korn och deras framstaellning
FI811422L (fi) Anordning foer stamkvistning och roejning
FI813526L (fi) Bensoheterocykliska foereningar och foerfarande foer deras framstaellning
FI811591L (fi) Stickugn och i denna infoerbar stickvagn
FI810712L (fi) Heterocykliska foereningar deras framstaellning och anvaendning
FI814163L (fi) Laodgjutningsfoerfarande och gjutanordning
FI812338L (fi) 9-amino-1-hydroxyoktahydrobenzo/c/kinoliner och deras derivat
FI810718L (fi) Slitbana foer daeck och daeck innehaollande en dylik slitbana
FI812215L (fi) 7-substituerade benzopyrander och foerfarande foer deras framstaellning
FI813524L (fi) Maleinsyra-anhydridkopolymerater och deras framstaellning
FI812504L (fi) Desinfekterande och steriliserande komposition
FI811532L (fi) Dioxidfoereningar foerfaranden foer deras framstaellning och deras anvaendning
FI65643B (fi) Spikplatta jaemte saett och anordning foer tillverkning av densamma
FI813604L (fi) Sek -butylbifenylprodukt och foerfarande foer framstaellning daerav
FI810916L (fi) Kirurgiskt haeftningsinstrument och styranordning
FI811900L (fi) Larvicider och insekticider
FI823488A0 (fi) Aromatiska formaldehydkompositioner och tandvaordskompositioner och tandvaordskompositioner innehaollande dessa
FI812206L (fi) Vaermekamin och vaermevaexlare foer vaermekamin
FI813801L (fi) Acylaminokinazolinderivater foerfarande foer deras framstaellning och farmaceutisk komposition innehaollande desamma
FI813845L (fi) N-pyrimidinyl-karbaminsyraestrar foerfarande foer deras framstaellning och dessa innehaollande laekemedel
FI821707A (fi) 7-oxoprostacyklinderivat och foerfarande foer deras framstaellning

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: PFIZER INC.